Here is the complete content for all 25 slides on ELISA for MBBS Biochemistry students:
SLIDE 1 — Title Slide
ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA)
Principles, Procedure, Types, Applications & Clinical Correlations
Department of Biochemistry | MBBS — Second Year
Lecture Series: Immunological Techniques
SLIDE 2 — Learning Objectives
By the end of this lecture, students will be able to:
- Define ELISA and state its full form
- Explain the biochemical principle behind ELISA
- Describe the step-by-step procedure
- Differentiate between the four major types of ELISA
- List clinical applications with disease examples
- Interpret a positive vs. negative ELISA result
- Discuss advantages, limitations, and clinical correlations
SLIDE 3 — Introduction: What is ELISA?
- Full form: Enzyme-Linked Immunosorbent Assay
- A labeled immunoassay considered the gold standard of immunoassays
- Developed by Engvall and Perlmann (1971) - originally for IgG quantification
- Detects and quantifies antigens, antibodies, proteins, hormones, and glycoproteins
- Based on specific antigen-antibody interaction linked to an enzyme reporter system
- Performed in 96-well microtiter plates (polystyrene)
- Results read by spectrophotometer/ELISA reader at specific wavelengths
SLIDE 4 — The Biochemical Principle
Core Principle: Antigen-Antibody Specificity + Enzyme Amplification
Three key elements:
- Immunological specificity — Antibody binds only its specific antigen (lock-and-key)
- Solid-phase adsorption — Antigen or antibody is immobilized onto a solid surface (polystyrene well)
- Enzyme amplification — Enzyme conjugated to antibody catalyzes a substrate reaction producing a measurable color change
Signal = Enzyme activity = Amount of antigen or antibody present
"The enzyme-linked antibodies can modify the specific substrates used to produce a color change within the preparation. The enzyme activity is measured with a colorimeter at a specific wavelength to determine the magnitude of infection."
SLIDE 5 — Key Components of ELISA
| Component | Role | Example |
|---|
| Antigen | Target molecule | HIV p24 protein, HBsAg |
| Primary Antibody | Binds specific antigen | Anti-HIV antibody |
| Secondary Antibody | Binds primary Ab (indirect) | Anti-IgG antibody |
| Enzyme conjugate | Reporter — amplifies signal | HRP, Alkaline Phosphatase |
| Substrate | Converted by enzyme to color | TMB (turns blue→yellow), pNPP |
| Blocking agent | Prevents nonspecific binding | BSA, skimmed milk, casein |
| Stop solution | Halts reaction, fixes color | H₂SO₄ (turns TMB yellow) |
| Microtiter plate | Solid phase — 96 wells | Polystyrene plate |
SLIDE 6 — Common Enzymes & Substrates Used
Enzyme: Horseradish Peroxidase (HRP)
- Substrate: TMB (3,3',5,5'-tetramethylbenzidine) → Blue color → Yellow after stop
- Substrate: OPD (o-phenylenediamine) → Orange-brown color
Enzyme: Alkaline Phosphatase (ALP)
- Substrate: pNPP (p-nitrophenyl phosphate) → Yellow color
- Substrate: BCIP/NBT → Blue-purple (used in Western blot variation)
Enzyme: Beta-galactosidase
- Substrate: ONPG → Yellow color (used in research settings)
Reading wavelength: TMB read at 450 nm after stop solution
SLIDE 7 — General ELISA Procedure (Step-by-Step)
Step 1 — COATING (Sensitization)
Antigen (or capture antibody) is adsorbed onto the polystyrene well surface. Incubate overnight at 4°C or 1-2 hours at 37°C.
Step 2 — BLOCKING
Add blocking buffer (BSA or casein). Incubate 1 hour. Prevents non-specific binding of antibodies to bare plastic.
Step 3 — WASHING
Wash with PBS-Tween (PBST) 3-5 times. Removes unbound blocking agents.
Step 4 — PRIMARY ANTIBODY INCUBATION
Add test sample or labeled primary antibody. Incubate 1-2 hours at 37°C. Specific binding occurs.
Step 5 — WASHING
Remove all unbound antibody with PBST.
Step 6 — ENZYME-CONJUGATED SECONDARY ANTIBODY
Add secondary antibody linked to enzyme. Incubate. Binds to primary antibody.
Step 7 — WASHING
Remove excess secondary antibody.
Step 8 — SUBSTRATE ADDITION
Add chromogenic substrate. Enzyme catalyzes color development (5-30 min).
Step 9 — STOP REACTION
Add stop solution (H₂SO₄). Color stabilizes.
Step 10 — READ (Spectrophotometry)
Read optical density (OD) at 450 nm. Compare to standard curve or cutoff value.
SLIDE 8 — Types of ELISA: Overview
Four Main Types:
| Type | Detects | Antibodies Used | Sensitivity |
|---|
| Direct ELISA | Antigen | 1 (enzyme-labeled) | Low |
| Indirect ELISA | Antibody | 2 (unlabeled + enzyme-labeled) | High |
| Sandwich ELISA | Antigen | 2 (capture + detection) | Highest |
| Competitive ELISA | Antigen/Antibody | Varies | High |
SLIDE 9 — Type 1: Direct ELISA
Principle: Antigen coated on plate → Enzyme-labeled primary antibody added directly → Substrate → Color
Procedure:
- Coat well with antigen (sample)
- Block nonspecific sites
- Add enzyme-conjugated primary antibody
- Wash
- Add substrate → Read color
Advantages: Fast, fewer steps, no cross-reactivity from secondary antibody
Disadvantages: Less sensitive, each primary antibody needs separate labeling, expensive
Application: Screening for antigen presence, detection of Mycoplasma bovis infection
SLIDE 10 — Type 2: Indirect ELISA
Principle: Antigen on plate → Unlabeled primary antibody binds → Enzyme-labeled secondary antibody binds to primary → Substrate → Color
Procedure:
- Coat well with antigen
- Block
- Add patient serum (primary antibody)
- Wash
- Add enzyme-labeled anti-human IgG (secondary antibody)
- Wash → Substrate → Stop → Read
Advantages: Higher sensitivity (multiple secondary antibodies per primary), one secondary antibody works for many primaries, cost-effective
Disadvantages: More steps, possible cross-reactivity, longer time
Application: HIV antibody screening (most widely used clinical ELISA), autoimmune disease antibody detection, TORCH serology
SLIDE 11 — Type 3: Sandwich ELISA
Principle: Capture antibody (specific for antigen) coated on plate → Antigen in sample binds → Detection antibody (different epitope) added → Enzyme-labeled secondary antibody → Substrate → Color
Forms a "Sandwich": Capture Ab — Antigen — Detection Ab
Procedure:
- Coat plate with capture antibody
- Block
- Add sample (antigen binds to capture Ab)
- Wash
- Add detection antibody (same or different species)
- Add enzyme-labeled secondary antibody
- Wash → Substrate → Stop → Read
Advantages: Most specific and sensitive, quantitative, can detect very low concentrations, works in complex samples (serum, urine)
Disadvantages: Both antibodies must recognize different epitopes, complex, expensive
Application: HBsAg detection, TSH/hCG quantification, COVID-19 antigen tests, cytokine measurement (IL-6, TNF-α)
SLIDE 12 — Type 4: Competitive ELISA
Principle: Competition between labeled and unlabeled antigen for limited antibody binding sites
Procedure:
- Coat well with antibody (or antigen)
- Add mixture of enzyme-labeled antigen + patient sample (unlabeled antigen)
- Both compete for the same antibody binding sites
- Wash → Substrate → Read
Interpretation (Inverse relationship):
- More antigen in sample → Less labeled antigen binds → LESS color = POSITIVE
- Less antigen in sample → More labeled antigen binds → MORE color = NEGATIVE
Advantages: Good for small antigens (haptens), works for samples with complex matrices
Disadvantages: Inverse reading is counterintuitive, requires careful calibration
Application: Drug screening (cocaine, amphetamines), hormone detection (cortisol, testosterone, estradiol), food safety testing
SLIDE 13 — ELISA Plate & Reading
The 96-Well Microtiter Plate:
- 8 rows (A-H) × 12 columns (1-12) = 96 wells
- Allows batch testing of multiple samples simultaneously
- Includes: Positive control, Negative control, Blank, Standards, Patient samples
Standard Curve:
- Known concentrations of antigen plotted against OD values
- Sigmoidal curve (4-parameter logistic regression)
- Unknown sample concentration read off the curve
Cutoff Value / S/CO ratio:
- Cutoff OD = Mean OD of negative controls × Cutoff factor (usually 2.1)
- Sample OD > Cutoff = Reactive (Positive)
- Sample OD < Cutoff = Non-Reactive (Negative)
ELISA Reader: Multichannel fiber-optic spectrophotometer reads all 96 wells in seconds
SLIDE 14 — ELISA vs. RIA (Comparison)
| Feature | ELISA | RIA (Radioimmunoassay) |
|---|
| Label | Enzyme | Radioactive isotope (¹²⁵I, ³H) |
| Detection | Colorimetry | Scintillation counter |
| Safety | Safe, no radiation | Radiation hazard |
| Shelf life | Long (months) | Short (weeks - due to decay) |
| Equipment | ELISA reader (cheap) | Gamma counter (expensive) |
| Sensitivity | High | Very High |
| Waste | Normal biohazard | Radioactive waste disposal |
| Use | Clinical diagnostics | Hormone assays (historical) |
RIA was the predecessor; ELISA replaced it for most clinical applications due to safety and practicality.
SLIDE 15 — Clinical Applications: Infectious Diseases
ELISA is the backbone of serological diagnosis:
| Disease | What ELISA Detects |
|---|
| HIV/AIDS | Anti-HIV antibodies (IgG/IgM) — 4th gen also detects p24 antigen |
| Hepatitis B | HBsAg (surface antigen), Anti-HBs, Anti-HBc, HBeAg |
| Hepatitis C | Anti-HCV antibodies |
| COVID-19 | Anti-SARS-CoV-2 antibodies (IgG/IgM), N-antigen |
| Dengue | NS1 antigen (early), IgM/IgG antibodies |
| Malaria | Plasmodium antigens (HRP-2) |
| Typhoid | Widal equivalent — Salmonella LPS antigens |
| TORCH infections | IgM/IgG to Toxoplasma, Rubella, CMV, HSV |
| Lyme disease | Anti-Borrelia antibodies |
| Syphilis | Anti-treponemal antibodies |
SLIDE 16 — Clinical Applications: Hormones & Tumor Markers
Endocrine & Reproductive:
| Analyte | Clinical Use |
|---|
| TSH, T3, T4 | Thyroid function tests |
| hCG (beta) | Pregnancy test, gestational trophoblastic disease |
| LH, FSH, Estradiol | Infertility workup, menstrual disorders |
| Cortisol, ACTH | Cushing's / Addison's disease |
| Insulin, C-peptide | Diabetes classification |
| Prolactin | Hyperprolactinemia, pituitary tumors |
Tumor Markers:
| Marker | Associated Cancer |
|---|
| AFP (Alpha-fetoprotein) | Hepatocellular carcinoma |
| PSA | Prostate cancer |
| CA-125 | Ovarian cancer |
| CA 19-9 | Pancreatic cancer |
| CEA | Colorectal cancer, lung |
| Beta-hCG | Choriocarcinoma |
SLIDE 17 — Clinical Applications: Autoimmune & Allergy
Autoimmune Diseases:
| Antibody Detected | Disease |
|---|
| Anti-dsDNA, Anti-Sm | Systemic Lupus Erythematosus (SLE) |
| Anti-CCP (cyclic citrullinated peptide) | Rheumatoid Arthritis |
| Anti-thyroglobulin, Anti-TPO | Hashimoto's thyroiditis |
| Anti-TSH receptor (TSI) | Graves' disease |
| Anti-ANA (antinuclear antibody) | Connective tissue diseases |
| Anti-endomysial, Anti-tTG (IgA) | Celiac disease |
| Anti-GBM | Goodpasture syndrome |
Allergy Testing:
- Total IgE and allergen-specific IgE (e.g., pollen, dust mites, peanut)
- RAST (RadioAllergoSorbent Test) - now replaced by ELISA-based ImmunoCAP
Blood Banking:
- Screening donated blood for HIV, HBV, HCV, syphilis
SLIDE 18 — Clinical Applications: Drug Monitoring & Food Safety
Therapeutic Drug Monitoring (TDM):
- Digoxin levels (cardiac glycoside toxicity monitoring)
- Cyclosporine, Tacrolimus (immunosuppressant monitoring in transplants)
- Phenytoin, Carbamazepine (anticonvulsant levels)
- Methotrexate (chemotherapy dosing)
Drugs of Abuse Screening:
- Cocaine / Benzoylecgonine (cocaine metabolite)
- Cannabis (THC metabolites)
- Amphetamines / MDMA (Ecstasy)
- Opioids, Benzodiazepines
- Used by forensic labs, workplace screening, doping control
Food Safety & Veterinary:
- Detection of allergens (peanut, gluten, milk proteins) in food products
- Pesticide residues in food
- Mycotoxins (aflatoxin) in grains
- Antibiotic residues in meat/milk
SLIDE 19 — Clinical Correlation 1: HIV Testing Algorithm
HIV Testing — The Standard Workflow:
Step 1 — Screening (4th Generation ELISA):
- Detects both HIV p24 antigen AND HIV IgM/IgG antibodies
- Window period: ~18 days (much shorter than 3rd gen)
- High sensitivity (~99.9%) — minimizes false negatives
Step 2 — Confirmatory (Western Blot or HIV-1/2 Antibody Differentiation Assay):
- High specificity — confirms reactive ELISA
- Avoids false positives from cross-reactive antibodies
Step 3 — If discordant: NAT (Nucleic Acid Test) for viral RNA
Clinical Pearl: A reactive ELISA alone does NOT diagnose HIV. Confirmation is mandatory. False positives can occur in pregnancy, autoimmune diseases, and recent vaccinations.
SLIDE 20 — Clinical Correlation 2: Hepatitis B Serology
HBV Markers Detected by ELISA:
| Marker | Meaning | ELISA Type |
|---|
| HBsAg (+) | Active infection | Sandwich ELISA |
| Anti-HBs (+) | Immunity (vaccination/recovery) | Indirect ELISA |
| HBeAg (+) | High viral replication | Sandwich ELISA |
| Anti-HBe (+) | Low replication / seroconversion | Indirect ELISA |
| Anti-HBc IgM (+) | Acute infection | Indirect ELISA |
| Anti-HBc IgG (+) | Past/chronic infection | Indirect ELISA |
Window Period concept: During window period — HBsAg has cleared but Anti-HBs not yet detectable — Anti-HBc IgM is the only marker
Clinical Pearl: HBsAg > 6 months = Chronic Hepatitis B. Monitoring: HBeAg seroconversion to Anti-HBe signals reduced infectivity.
SLIDE 21 — Clinical Correlation 3: Thyroid Function & Pregnancy
TSH ELISA (Sandwich type):
- Most sensitive test for thyroid dysfunction
- 3rd generation TSH assay: detects as low as 0.01 mIU/L
- Screening for hypothyroidism in newborns (heel-prick blood spot)
hCG ELISA:
- Qualitative: Pregnancy test strips (direct ELISA principle)
- Quantitative: Serial beta-hCG levels in ectopic pregnancy, molar pregnancy, choriocarcinoma monitoring
- hCG doubling time in early pregnancy: should double every 48-72 hours
- Falling hCG: miscarriage, failed ectopic treatment
Anti-TPO ELISA:
- Hashimoto's thyroiditis: Anti-TPO > 35 IU/mL (positive)
- Present in 95% of Hashimoto's, 85% of Graves' disease patients
SLIDE 22 — Advantages & Disadvantages of ELISA
Advantages:
- High sensitivity and specificity
- Can detect very low concentrations (picogram/mL range)
- Quantitative results (standard curve)
- Safe — no radioactivity (unlike RIA)
- High throughput — 96 samples per plate
- Relatively inexpensive and widely available
- Long shelf life of reagents
- Automated platforms available (CLIA analyzers in hospitals)
- Can be performed in resource-limited settings (rapid ELISA strips)
Disadvantages / Limitations:
- Requires pure, specific antibodies
- False positives: nonspecific binding, rheumatoid factor, heterophile antibodies, cross-reactive antigens
- False negatives: window period, prozone effect (antibody excess), degraded samples
- Does not detect the actual pathogen (detects antibody response)
- Temperature and time-sensitive (must follow protocol strictly)
- Cannot distinguish active from past infection without IgM/IgG differentiation
SLIDE 23 — Causes of False Results
False Positive ELISA:
- Rheumatoid factor (IgM anti-IgG) — interferes with indirect ELISA
- Heterophile antibodies (cross-react with animal-derived detection antibodies)
- Nonspecific adsorption (inadequate blocking)
- Cross-reactive antigens (e.g., HIV ELISA false positive in autoimmune disease, malaria, pregnancy)
- Contamination between wells
False Negative ELISA:
- Window period (antibodies not yet formed — e.g., first 18 days of HIV)
- Prozone / Hook effect — very high antigen/antibody excess saturates binding; no sandwich forms
- Immunocompromised patients (cannot mount antibody response)
- Improper storage of kit or samples (enzyme denaturation)
- Hemolyzed, lipemic, or icteric samples (interfere with colorimetry)
Clinical Pearl: The Hook Effect is especially important in Sandwich ELISA for tumor markers — extremely elevated AFP/hCG may give falsely LOW readings. Always dilute sample if clinical suspicion is high.
SLIDE 24 — ELISA in Point-of-Care & Rapid Testing
Rapid ELISA / Lateral Flow Assays (Modern Extensions):
- Miniaturized ELISA principle on a nitrocellulose membrane strip
- No lab equipment needed — results in 15-30 minutes
- Examples:
- Rapid HIV test (OraQuick, SD Bioline)
- Rapid HBsAg test
- COVID-19 rapid antigen/antibody test
- Malaria RDT (Rapid Diagnostic Test) - HRP-2 antigen
- Pregnancy test strip (hCG)
CLIA (Chemiluminescence Immunoassay):
- Uses chemiluminescent substrate instead of chromogenic
- Higher sensitivity than conventional ELISA
- Used in automated hospital analyzers (Abbott Architect, Roche Elecsys)
- Applications: Troponin I (AMI), TSH, HIV combo, HBsAg
Most modern hospital immunoassay analyzers use CLIA principle — an evolution of ELISA.
SLIDE 25 — Summary & Key Take-Home Points
Remember with the mnemonic "ELISA CLIPS":
-
E — Enzyme linked (HRP, ALP)
-
L — Labeled antibody amplifies signal
-
I — Immunological specificity (Ag-Ab)
-
S — Solid phase (96-well polystyrene plate)
-
A — Absorbance read at 450 nm
-
C — Color change = positive result
-
L — 4 types: Direct, Indirect, Sandwich, Competitive
-
I — Indirect = HIV screening; Sandwich = most sensitive
-
P — Prozone/hook effect = false negative at high concentrations
-
S — Sensitivity: Sandwich > Indirect > Direct > Competitive
Key Clinical Uses to Remember:
HIV (4th gen combo) | HBsAg | Dengue NS1 | TSH | hCG | Anti-dsDNA | Tumor markers
Principle in one sentence:
Antigen-antibody complex, immobilized on solid phase, detected by enzyme-catalyzed color change, read spectrophotometrically.
References: Janeway's Immunobiology 10e | Harper's Biochemistry | Tietz Clinical Chemistry | WHO HIV Testing Guidelines
That's the full 25-slide content. Each slide is structured for a lecture format with clear headings, tables, clinical pearls, and mnemonics appropriate for MBBS biochemistry students. Let me know if you'd like any slide revised, expanded, or if you now want me to generate the actual PowerPoint file.